Literature DB >> 16935318

Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.

Alexey Seregin1, Ryan Nistler, Victoria Borisevich, Galina Yamshchikov, Elena Chaporgina, Chun Wai Kwok, Vladimir Yamshchikov.   

Abstract

The exceptionally high virulence of the West Nile NY99 strain makes its suitability in the development of a live WN vaccine uncertain. The aim of this study is to investigate the immunogenicity of noninfectious virus derivatives carrying pseudolethal mutations, which preclude virion formation without affecting preceding steps of the viral infectious cycle. When administered using DNA immunization, such constructs initiate an infectious cycle but cannot lead to a viremia. While the magnitude of the immune response to a noninfectious replication-competent construct was lower than that of virus or infectious DNA, its overall quality and the protective effect were similar. In contrast, a nonreplicating construct of similar length induced only a marginally detectable immune response in the dose range used. Thus, replication-competent noninfectious constructs derived from infectious DNA may offer an advantageous combination of the safety of noninfectious formulations with the quality of the immune response characteristic of infectious vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935318     DOI: 10.1016/j.virol.2006.07.038

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

Review 1.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

Review 2.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virions.

Authors:  Petra Schlick; Christian Taucher; Beate Schittl; Janina L Tran; Regina M Kofler; Wolfgang Schueler; Alexander von Gabain; Andreas Meinke; Christian W Mandl
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

4.  West Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles.

Authors:  Justin A Roby; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

5.  Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.

Authors:  Xiaohong Jiang; Tim J Dalebout; Igor S Lukashevich; Peter J Bredenbeek; David Franco
Journal:  J Gen Virol       Date:  2014-12-16       Impact factor: 3.891

6.  A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity.

Authors:  Judith Edmonds; Erinke van Grinsven; Natalie Prow; Angela Bosco-Lauth; Aaron C Brault; Richard A Bowen; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

7.  A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.

Authors:  Byron E E Martina; Petra van den Doel; Penelope Koraka; Geert van Amerongen; Gunther Spohn; Bart L Haagmans; Lisette B V Provacia; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

8.  Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model.

Authors:  José Peña; Jessica A Plante; Alda Celena Carillo; Kimberly K Roberts; Jennifer K Smith; Terry L Juelich; David W C Beasley; Alexander N Freiberg; Montiago X Labute; Pejman Naraghi-Arani
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

9.  IS-98-ST1 West Nile virus derived from an infectious cDNA clone retains neuroinvasiveness and neurovirulence properties of the original virus.

Authors:  Céline Bahuon; Philippe Desprès; Nathalie Pardigon; Jean-Jacques Panthier; Nathalie Cordonnier; Steeve Lowenski; Jennifer Richardson; Stéphan Zientara; Sylvie Lecollinet
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

Review 10.  Vaccines in development against West Nile virus.

Authors:  Samantha Brandler; Frederic Tangy
Journal:  Viruses       Date:  2013-09-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.